BioArctic

🌟 International Day of Women and Girls in Science 🌟 At BioArctic, we want to highlight the International Day of Women and Girls in Science on February 11th. With 64% women in our organization, 56% in corporate management, 63% as managers, and 59% with a PhD, we demonstrate that we have succeeded in creating good conditions for women to develop in science and entrepreneurship. We would like to introduce two of our role models - our CEO Gunilla Osswald and Chief Research Officer Johanna Fälting. A diversity of perspectives and experiences is the key to innovation and success. We want to inspire and support more women and girls to choose a career in science. #STEM #WomenInScience #GirlsInSTEM

Today marks the 10th anniversary of the International Day of Women and Girls in Science. At BioArctic, we are proud to honor the amazing women who drive and contribute to research and innovation within our organization. To mark this day, we have asked some questions to Ebba Amandius, Lisa Sandersjöö and Sofia Gustafsson at BioArctic, about why they became scientists and their perspective on equality within the field. #STEM #WomenInScience #GirlsInSTEM

Today, BioArctics founder Lars Lannfelt is keynote speaker at BioCapital Europes conference in Amsterdam. We are pround that Prof Lannfelts research in #Alzheimers disease is widely recognized. BioCapital is EQT Life Sciences key life science investment conference in Europe. BioArctic is represented by Oskar Bosson VP IR and Coms.

We now welcome Rebecca Kastell as Vice President Head of HR at BioArctic. Rebecca takes over after Gunilla Andersson who is retiring this year. Gunilla has contributed to BioArctic's growth, from 30 employees to the listed and successful company it is today. Rebecca has spent most of her career at the intersection of business growth, leadership, and personnel strategy. She has helped companies expand, internationalize, and build strong cultures. Now she looks forward to collaborating with her team and colleagues to continue developing BioArctic. What brought Rebecca to BioArctic is the company’s clear purpose - to make a real difference in people’s lives. 🔷 How would you describe your leadership? - Leadership is a relationship that needs to be adapted to the individual, the team, the goal and the company. The core ingredients for me are trust, dialogue, transparency, self-awareness and fun as well as always keeping the vision and big picture in mind. The best moments in my role as a leader have been when the team achieves meaningful milestones together, when there is real conversation and connection and when people break boundaries in what they believe they can do and take leaps to achieve their potential. 🔷 How do you work to create open and inclusive communication with your colleagues/team? - A dialogue that is characterized by curiosity, genuineness and directness tends to build relationships where people can be themselves, which is a prerequisite for an open and inclusive communication. Also, I find that systematically asking for rewarding and welcoming differences in opinion and new perspectives are ways to build a constructive communication climate. 🔷 What qualities do you consider most important when recruiting? - Beyond following a science-based approach to recruitment to get the right skills, experience and personal qualities, we look for people who are genuinely motivated by the mission of BioArctic. Alignment with our culture, values and willingness to collaborate are also important aspects. You can read more about BioArctic’s executive leadership on our website https://lnkd.in/dEsMSdFe #leadership #corporateculture #development #internationalize

Join BioArctic as an HR Business Partner! Are you an experienced HR Business Partner who wants to be part of shaping the future of BioArctic? As our HR Business Partner, you will play a key role in shaping the future of our organization by attracting top talent and supporting a broad range of HR initiatives. Visit our site and read more!

We are tremendously proud that the Swedish Government has appointed BioArctics Head of Research Johanna Fälting as industry representative and subject expert for medicine and health to the Vetenskapsrådet / Swedish Research Council. Congratulations Johanna 🌟

We have had the honor of welcoming professor Bengt Winblad and Gunilla Johansson to the BioArctic office. They were interviewed on stage by Sr. Medical Director Sven Erickson. Bengt and Gunilla shared interesting thoughts about the research and development within the field of #Alzheimer’s disease and also gave a personal vision for the future. Very inspirational, thank you for the visit – and welcome back anytime.

Happy data protection day! 💻 Data protection and data privacy are extra important in the pharmaceutical industry. Data privacy is not only about respecting the law but even more importantly to build trust and to show respect for the individual. We are grateful for the sensitive data that individs share in order to advance science and therefore we have taken the opportunity to raise awareness within the organization so that we all understand the responsibilities and privilege we share. #dataprotection #dataprivacy #gdpr #trust

This week BioArctic is attending the JP Morgan Healthcare week with a fully packed schedule of meetings. The interest in BioArctic’s portfolio and BrainTransporter(TM) technology is certainly tangible. 🧬🧪💡🇸🇪 The #JPM is a great week to connect with business development colleagues in pharma, biotech, as well as investors. All curious to learn more and discuss future partnerships. Don’t hesitate to say hello the the team with CEO Gunilla Osswald, CFO Anders Martin-Löf, Head of Research Johanna Fälting, Business Development Petter Wereen, VP Science and Technology Per-Ola Freskgård and VP IR & Coms Oskar Bosson if you run into them. #biotech #innovation #partnership #antibodies #bloodbraintransport

BioArctic söker nu en NeuroScience Account Manager, region Väst/Sydöst. Rollen ska ge ovärderligt stöd till sjukvården i implementeringen av en helt ny patientresa inför lanseringen av ett nytt läkemedel mot Alzheimers sjukdom. De blir del av ett växande svenskt forskningsfokuserat biofarmaföretag med en optimistisk ”can-do” attityd och ett engagerat och mycket skickligt team. Tillsammans har vi massor av spännande uppgifter framför oss!